PeckiiLess will not only remove the invasiveness, waste and high cost of current methods, we will offer an accurate monitoring product for the roughly 40% of people who need to check their glucose but do not have access to the technology due to their limitations. The purpose of the application

Most SCLC patients survive one year or less after diagnosis. Our aim is to develop a drug against SCLC, which is both more effective than the current treatment recommendations and which also leads to fewer side effects. The hypothesis that we want to evaluate is whether treatment with L12 shows

Our solution is perfectly suited for the screening of the population above 50 years. As 40 percent of dementia are preventable by lifestyle changes, being able to screen the entire population could prevent ten million cases of Alzheimer’s. What is more, if an effective medication is put on the market

The goal of the project is to in a smart, quick and safe way assess movement quality in different environments (e.g., by physiotherapists, occupational therapists, ergonomists, in sports and the workplace) by developing and evaluating a method where artificial intelligence assesses movement quality via a mobile application. The results from

The aim of the project is to develop a new cancer treatment in the form of antibodies to SLAMF6 that can activate the body’s own T cells to attack cancer stem cells, primarily in acute myeloid leukaemia (AML) but potentially also in other cancers. The funds sought would enable the

The aim is to eventually develop an antibody-based treatment that attacks the leukemic stem cells in AML. We have discovered a certain receptor shows specifically on the cell surface in one of the most common forms of AML. The receptor does not shown on normal blood stem cells and with